140 related articles for article (PubMed ID: 35516677)
1. Mucormycosis following COVID-19 infection-An epidemic developing in a pandemic, a case series from a tertiary care hospital of India.
Singhai A; Unnikrishnan S; Jain P
J Family Med Prim Care; 2022 Apr; 11(4):1568-1572. PubMed ID: 35516677
[TBL] [Abstract][Full Text] [Related]
2. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
[TBL] [Abstract][Full Text] [Related]
3. Role of COVID 19 Inflammatory Markers in Rhino-Orbito-Cerebral Mucormycosis: A Case Study in Predisposed Patients at a Designated Nodal Centre.
Goddanti N; Reddy YM; Kumar MK; Rajesh M; Reddy LS
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3498-3504. PubMed ID: 34804904
[TBL] [Abstract][Full Text] [Related]
4. COVID-19-associated mucormycosis in India: Why such an outbreak?
Pasquier G
J Mycol Med; 2023 Aug; 33(3):101393. PubMed ID: 37182234
[TBL] [Abstract][Full Text] [Related]
5. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
Mehfooz S; Mehrotra N; Usmani T; Raj V
Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
[TBL] [Abstract][Full Text] [Related]
6. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
[TBL] [Abstract][Full Text] [Related]
7. Emergence of Rhino-Orbito-Cerebral Mucormycosis in Peru: Impact of the COVID-19 Pandemic.
Cumpa-Quiroz R; Elguera-Falcón F; Guevara-Lazo DR
Cureus; 2023 Sep; 15(9):e45240. PubMed ID: 37842460
[TBL] [Abstract][Full Text] [Related]
8. Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic.
Mehta RM; Bansal S; Kalpakkam H
Lung India; 2022; 39(2):187-190. PubMed ID: 35259803
[TBL] [Abstract][Full Text] [Related]
9. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
10. A case series of post COVID-19 mucormycosis-a neurological prospective.
Roushdy T; Hamid E
Egypt J Neurol Psychiatr Neurosurg; 2021; 57(1):100. PubMed ID: 34335016
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of COVID-19-Associated Mucormycosis.
Tayabali K; Pothiwalla H; Narayanan S
Curr Fungal Infect Rep; 2023 May; ():1-20. PubMed ID: 37360859
[TBL] [Abstract][Full Text] [Related]
12. As the virus sowed, the fungus reaped! A comparative analysis of the clinico-epidemiological characteristics of rhino-orbital mucormycosis before and during COVID-19 pandemic.
Muraleedharan M; Panda NK; Angrish P; Arora K; Patro SK; Bansal S; Chakrabarti A; Rudramurthy SM; Bakshi J; Mohindra S; Gupta R; Virk RS; Verma RK; Ramavat AS; Nayak G
Mycoses; 2022 May; 65(5):567-576. PubMed ID: 35289000
[TBL] [Abstract][Full Text] [Related]
13. Mucormycosis, New Causative Agents, and New Susceptible Populations: Review of Cases in a Tertiary Care Hospital in Iran (2007-2021).
Darazam IA; Babamahmoodi A; Ebrahimi MJ; Moafi M; Dilmaghani NA; Mardani M; Shokouhi S; Gharehbagh FJ; Chalmiani EM; Shabani M; Bidari F; Jamali E; Khoshsirat S; Shahriari M; Sabeti S; Rahmani Z; Mousavinejad SA; Ebrahimzadeh K; Hallajnejad M
Iran J Public Health; 2023 Nov; 52(11):2467-2473. PubMed ID: 38106820
[TBL] [Abstract][Full Text] [Related]
14. Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of Covid-19: The Indian Scenario.
Bhardwaj R; Sharma A; Parasher A; Gupta H; Sahu S; Pal S
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3492-3497. PubMed ID: 34786356
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and mucormycosis superinfection: the perfect storm.
Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Associated Mucormycosis.
Tazeem S; Nagaraju A; Begum H; Tommi JA; Sudarshan Reddy L; Vijay Kumar M
Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(4):1-9. PubMed ID: 37362123
[TBL] [Abstract][Full Text] [Related]
17. COVID19 associated mucormycosis: A review.
Palanisamy PR; Elango D
J Family Med Prim Care; 2022 Feb; 11(2):418-423. PubMed ID: 35360784
[TBL] [Abstract][Full Text] [Related]
18. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
Singh AK; Singh R; Joshi SR; Misra A
Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
[TBL] [Abstract][Full Text] [Related]
20. Trends of rhino-orbito-cerebral mucormycosis in COVID-19 patients: An observational study.
Singh N; Singh S; Singh P; Mishra N; Sinha BP; Shrama AK
J Family Med Prim Care; 2022 Dec; 11(12):7891-7896. PubMed ID: 36994064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
